Eledon Pharmaceuticals (ELDN) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 16.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.83% |
| Dec 31, 2025 | 18.70% |
| Sep 30, 2025 | 3.58% |
| Jun 30, 2025 | 5.29% |
| Mar 31, 2025 | 9.42% |
| Dec 31, 2024 | 47.45% |
| Sep 30, 2024 | -4.44% |
| Jun 30, 2024 | 14.62% |
| Mar 31, 2024 | -1.53% |
| Dec 31, 2023 | 1.01% |
| Sep 30, 2023 | 25.46% |
| Jun 30, 2023 | 105.91% |
| Mar 31, 2023 | 46.75% |
| Dec 31, 2022 | 82.37% |
| Sep 30, 2022 | 112.72% |
| Jun 30, 2022 | 54.40% |
| Mar 31, 2022 | 118.00% |
| Dec 31, 2021 | 40.51% |
| Sep 30, 2021 | 105.04% |
| Jun 30, 2021 | 71.39% |
| Mar 31, 2021 | 122.52% |
| Dec 31, 2020 | 104.85% |
| Sep 30, 2020 | 80.22% |
| Jun 30, 2020 | 14.86% |
| Mar 31, 2020 | 60.35% |
| Dec 31, 2019 | 103.11% |
| Sep 30, 2019 | -29.43% |
| Jun 30, 2019 | -14.18% |
| Mar 31, 2019 | -40.90% |
| Dec 31, 2018 | -4.78% |
| Sep 30, 2018 | -33.45% |
| Jun 30, 2018 | -12.64% |
| Mar 31, 2018 | -36.67% |
| Dec 31, 2017 | -31.06% |
| Sep 30, 2017 | -49.70% |
| Jun 30, 2017 | -19.59% |
| Mar 31, 2017 | 5.61% |
| Dec 31, 2016 | -34.03% |
| Sep 30, 2016 | 139.54% |